Bayer (OTCPK:BAYRY -1.6%) has agreed to settle ~90% of the 39K claims in the U.S. over alleged injuries related to its Essure permanent implanted birth control device.
Under the terms of the settlements, it will pay a total of $1.60B (€1.35B) without admitting liability or wrongdoing.
Talks to resolve the remaining ~10% of claims are in process.
The company stopped selling the product in 2018 but did not recall the units in the field.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.